Lavoz, C.; Rodrigues-Diez, R.R.; Plaza, A.; Carpio, D.; Egido, J.; Ruiz-Ortega, M.; Mezzano, S.
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy. J. Clin. Med. 2020, 9, 302.
https://doi.org/10.3390/jcm9020302
AMA Style
Lavoz C, Rodrigues-Diez RR, Plaza A, Carpio D, Egido J, Ruiz-Ortega M, Mezzano S.
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy. Journal of Clinical Medicine. 2020; 9(2):302.
https://doi.org/10.3390/jcm9020302
Chicago/Turabian Style
Lavoz, Carolina, Raul R. Rodrigues-Diez, Anita Plaza, Daniel Carpio, Jesús Egido, Marta Ruiz-Ortega, and Sergio Mezzano.
2020. "VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy" Journal of Clinical Medicine 9, no. 2: 302.
https://doi.org/10.3390/jcm9020302
APA Style
Lavoz, C., Rodrigues-Diez, R. R., Plaza, A., Carpio, D., Egido, J., Ruiz-Ortega, M., & Mezzano, S.
(2020). VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy. Journal of Clinical Medicine, 9(2), 302.
https://doi.org/10.3390/jcm9020302